DexCom, Inc. (DXCM)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
27-Sep-17 7:49 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 25-Sep-17Market Sale (Planned) 1,450$69.81$101,219.00(1%)
100.78K to 99.33K
3%
27-Sep-17 7:49 PM
View: 
Doubleday Richard
EVP, Chief Commercial Officer
DexCom, Inc. (DXCM) 25-Sep-17Market Sale (Planned) 1,635$69.77$114,080.00(2%)
88.83K to 87.2K
3%
22-Sep-17 6:13 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 20-Sep-17Market Sale (Planned) 6,000$69.34$416,044.00(2%)
304.83K to 298.83K
(< 1%)
13-Sep-17 6:36 PM
View: 
Moy Jeffrey
SVP, Operations
DexCom, Inc. (DXCM) 11-Sep-17Disposition 6,430$71.81$461,760.00(5%)
134.41K to 127.98K
(3%)
13-Sep-17 6:23 PM
View: 
Leach Jacob Steven
SVP, Research & Development
DexCom, Inc. (DXCM) 11-Sep-17Disposition 6,342$71.81$455,441.00(4%)
144.36K to 138.02K
(3%)
13-Sep-17 6:23 PM
View: 
Balo Andrew K
EVP, Reg. Strategy, Clinical
DexCom, Inc. (DXCM) 11-Sep-17Market Sale (Planned) 3,244$72.27$234,441.00(4%)
92.53K to 89.28K
(2%)
13-Sep-17 6:38 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 11-Sep-17Disposition 15,854$71.81$1,138,530.00(5%)
320.68K to 304.83K
(3%)
13-Sep-17 6:22 PM
View: 
Doubleday Richard
EVP, Chief Commercial Officer
DexCom, Inc. (DXCM) 11-Sep-17Disposition 7,531$71.81$540,827.00(8%)
96.36K to 88.83K
(3%)
13-Sep-17 6:36 PM
View: 
Moy Jeffrey
SVP, Operations
DexCom, Inc. (DXCM) 11-Sep-17Acquisition (other) 12,166$71.26$866,949.0010%
122.24K to 134.41K
3%
13-Sep-17 6:38 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 11-Sep-17Disposition 7,311$71.81$525,028.00(7%)
108.09K to 100.78K
(3%)
13-Sep-17 6:23 PM
View: 
Balo Andrew K
EVP, Reg. Strategy, Clinical
DexCom, Inc. (DXCM) 11-Sep-17Disposition 7,531$71.81$540,827.00(8%)
100.06K to 92.53K
(3%)
13-Sep-17 6:37 PM
View: 
Murphy Patrick Michael
VP, Legal Aff & Chf Compl Ofcr
DexCom, Inc. (DXCM) 11-Sep-17Disposition 1,322$71.81$94,937.30(4%)
34.45K to 33.13K
(3%)
13-Sep-17 6:36 PM
View: 
Moy Jeffrey
SVP, Operations
DexCom, Inc. (DXCM) 11-Sep-17Disposition (other) 12,166$71.26$866,949.00(10%)
127.98K to 115.81K
(3%)
08-Sep-17 7:47 PM
View: 
Blackford Quentin S.
EVP, CFO, PFO & PAO
DexCom, Inc. (DXCM) 07-Sep-17Grant 62,358$0.00$62.364461%
1.4K to 63.76K
24-Aug-17 7:31 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-Aug-17Market Sale (Planned) 3,987$75.26$300,045.00(4%)
112.07K to 108.09K
< 1%
24-Aug-17 7:31 PM
View: 
Ace Heather S
SVP Human Resources
DexCom, Inc. (DXCM) 23-Aug-17Disposition 2,617$75.33$197,145.00(5%)
49.38K to 46.77K
< 1%
24-Aug-17 7:31 PM
View: 
Doubleday Richard
EVP, Chief Commercial Officer
DexCom, Inc. (DXCM) 23-Aug-17Market Sale (Planned) 1,635$75.26$123,053.00(2%)
97.81K to 96.18K
< 1%
15-Aug-17 5:52 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 11-Aug-17Market Sale (Planned) 6,000$69.77$418,637.00(2%)
326.68K to 320.68K
(3%)
11-Aug-17 5:54 PM
View: 
Balo Andrew K
EVP, Reg. Strategy, Clinical
DexCom, Inc. (DXCM) 10-Aug-17Market Sale (Planned) 3,244$71.18$230,921.00(3%)
103.23K to 99.99K
2%
25-Jul-17 8:55 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 24-Jul-17Market Sale (Planned) 1,450$69.47$100,725.00(1%)
113.52K to 112.07K
(< 1%)
12-Jul-17 5:33 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 12-Jul-17Market Sale (Planned) 6,000$71.86$431,174.00(2%)
332.68K to 326.68K
< 1%
12-Jul-17 5:32 PM
View: 
Balo Andrew K
EVP, Reg. Strategy, Clinical
DexCom, Inc. (DXCM) 10-Jul-17Market Sale (Planned) 3,200$71.55$228,972.00(3%)
106.43K to 103.23K
< 1%
27-Jun-17 6:55 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-Jun-17Market Sale (Planned) 1,450$78.19$113,378.00(1%)
114.97K to 113.52K
2%
27-Jun-17 6:56 PM
View: 
Doubleday Richard
EVP, Chief Commercial Officer
DexCom, Inc. (DXCM) 23-Jun-17Market Sale (Planned) 3,187$78.22$249,273.00(3%)
101.0K to 97.81K
3%
13-Jun-17 5:26 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 12-Jun-17Market Sale (Planned) 6,000$69.07$414,411.00(2%)
338.68K to 332.68K
< 1%
13-Jun-17 5:27 PM
View: 
Balo Andrew K
EVP, Clinical and Regulatory
DexCom, Inc. (DXCM) 12-Jun-17Market Sale (Planned) 3,200$69.06$220,989.00(3%)
109.63K to 106.43K
< 1%
05-Jun-17 8:02 PM
View: 
Abbey Donald
EVP Quality
DexCom, Inc. (DXCM) 01-Jun-17Disposition 7,784$66.38$516,707.00(9%)
82.51K to 74.73K
(3%)
05-Jun-17 8:50 PM
View: 
Kahn Barbara
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 4,353$0.00$4.3517%
26.09K to 30.45K
05-Jun-17 8:50 PM
View: 
Skyler Jay S
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 4,553$0.00$4.5514%
32.26K to 36.81K
05-Jun-17 8:49 PM
View: 
Augustinos Nicholas
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 4,353$0.00$4.3516%
26.66K to 31.02K
05-Jun-17 8:48 PM
View: 
Foletta Mark G
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 4,952$0.00$4.9532%
15.64K to 20.59K
05-Jun-17 8:47 PM
View: 
Topol Eric
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 4,653$0.00$4.655%
99.91K to 104.56K
05-Jun-17 8:48 PM
View: 
Collins Richard Alexander
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 5,355$0.00$5.361071%
0.5K to 5.86K
05-Jun-17 8:47 PM
View: 
Altman Steven R
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 4,353$0.00$4.3519%
23.5K to 27.86K
26-May-17 4:24 PM
View: 
Gregg Terrance H
Executive Chairman
Director
DexCom, Inc. (DXCM) 24-May-17Option Exercise 30,000$6.85$205,500.006%
506.9K to 536.9K
25-May-17 7:15 PM
View: 
Doubleday Richard
EVP, Chief Commercial Officer
DexCom, Inc. (DXCM) 23-May-17Market Sale (Planned) 3,182$68.29$217,290.00(3%)
104.18K to 101.0K
< 1%
25-May-17 7:16 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-May-17Market Sale (Planned) 1,450$68.24$98,949.00(1%)
116.42K to 114.97K
< 1%
18-May-17 5:46 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 17-May-17Option Exercise 3,649$8.79$32,074.701%
343.68K to 347.33K
18-May-17 5:46 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 17-May-17Market Sale (Planned) 5,000$68.39$341,961.00(1%)
343.68K to 338.68K
18-May-17 5:46 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 17-May-17Market Option Sale (Planned) 3,649$68.39$249,563.00(1%)
347.33K to 343.68K
17-May-17 7:36 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 16-May-17Gift 1,000----(< 1%)
117.42K to 116.42K
12-May-17 6:19 PM
View: 
Balo Andrew K
EVP, Clinical and Regulatory
DexCom, Inc. (DXCM) 10-May-17Market Sale (Planned) 3,200$71.93$230,176.00(3%)
112.83K to 109.63K
4%
26-Apr-17 7:04 PM
View: 
Doubleday Richard
EVP, Chief Commercial Officer
DexCom, Inc. (DXCM) 24-Apr-17Market Sale (Planned) 3,182$75.78$241,131.00(3%)
107.37K to 104.18K
1%
26-Apr-17 7:04 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 24-Apr-17Market Sale (Planned) 1,450$75.89$110,041.00(1%)
118.87K to 117.42K
1%
24-Apr-17 6:13 PM
View: 
Gregg Terrance H
Executive Chairman
Director
DexCom, Inc. (DXCM) 20-Apr-17Market Sale 15,000$74.10$1,111,500.00(3%)
521.9K to 506.9K
(2%)
19-Apr-17 5:20 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 17-Apr-17Market Option Sale (Planned) 10,000$75.63$756,317.00(3%)
353.68K to 343.68K
19-Apr-17 5:20 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 17-Apr-17Option Exercise 10,000$8.79$87,900.003%
343.68K to 353.68K
12-Apr-17 5:31 PM
View: 
Balo Andrew K
EVP, Clinical and Regulatory
DexCom, Inc. (DXCM) 10-Apr-17Market Sale (Planned) 3,200$78.19$250,208.00(3%)
116.03K to 112.83K
1%
24-Mar-17 5:54 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-Mar-17Market Sale (Planned) 3,987$76.25$304,006.00(3%)
122.86K to 118.87K
(11%)
24-Mar-17 5:53 PM
View: 
Doubleday Richard
EVP, Chief Commercial Officer
DexCom, Inc. (DXCM) 23-Mar-17Market Sale (Planned) 3,182$76.38$243,029.00(3%)
110.55K to 107.37K
(11%)